A Genotype-Phenotype Urothelial Cancer Study

Share

Full Title

A Genotype-Phenotype Urothelial Cancer Registry

Purpose

Urothelial cancers affect the urinary system. This study is being done to create a registry to learn more about these cancers, enabling researchers to look at large groups of people with and without this kind of cancer.

Researchers will look at risk factors to learn more about their relationship to cancer. They will also look at genetic markers in saliva which may be associated with a particular trait. It is hoped that certain genes identified in patients may predict cancer risk or response to treatment.

This registry may lead to better methods of preventing, diagnosing, and treating urothelial cancers. Participants will include those with and without urothelial cancers. They will be asked to complete a questionnaire about risk factors (such as smoking, occupational exposures, alcohol use, and family medical history) and provide samples such as saliva and/or blood, and (in the case of people with urothelial cancer who are having a biopsy or surgery) tumor tissue.

Who Can Join

Participants in this study will include people age 18 and older with urothelial cancers. People who accompany study participants to clinic may also take part in the study, as long as they have never had cancer and are not blood relatives of any study participants. Participants must be able to speak English.

For more information about this study and to inquire about eligibility, please contact Dr. Dean Bajorin at 646-888-4700.

Protocol

09-025

Investigator

ClinicalTrials.gov ID

NCT00902590